Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins

被引：0
|
作者：
Nyarko, KA
Freedman, J
Song, YQ
Gentry, PA
Ofosu, FA
机构：
[1] Univ Guelph, Guelph, ON N1G 2W1, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2588
引用
收藏
页码：817 / 817
页数：1
相关论文
共 50 条
  • [31] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis
    Lin, C.
    Aberson, H. L.
    Von der Thusen, J.
    Borensztajn, K.
    Spek, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [33] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Yamaguchi, Akio
    [J]. ANTICANCER RESEARCH, 2008, 28 (2A) : 847 - 854
  • [34] Astrocyte Activation by Neuronal Prothrombin via Protease-Activated Receptors (PAR-1)
    Lyden, Patrick D.
    Lamb, Jessica A.
    Kothari, Shweta
    Rajput, Padmesh S.
    Lyden, Patrick
    [J]. ANNALS OF NEUROLOGY, 2017, 82 : S39 - S39
  • [35] Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1
    Sharma, Mehul
    Merkulova, Yulia
    Raithatha, Sheetal
    Parkinson, Leigh G.
    Shen, Yue
    Cooper, Dawn
    Granville, David J.
    [J]. FEBS JOURNAL, 2016, 283 (09) : 1734 - 1747
  • [36] Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats
    Andrade-Gordon, P
    Derian, CK
    Maryanoff, BE
    Zhang, HC
    Addo, MF
    Cheung, WM
    Damiano, BP
    D'Andrea, MR
    Darrow, AL
    De Garavilla, L
    Eckardt, AJ
    Giardino, EC
    Haertlein, BJ
    McComsey, DF
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 34 - 42
  • [37] IN VIVO PROTEASE-ACTIVATED RECEPTOR-1 MEDIATED CORONARY VASOREACTIVITY CORRELATES WITH PAR-1 EXPRESSION DISTRIBUTION IN THE CORONARY VASCULAR WALL
    Kasasbeh, E. S.
    Phillips, S. A.
    Couhtino, L.
    Williams, P.
    Nunnally, A. H.
    Adcock, J.
    Wang, L.
    Hamm, H. E.
    Cleator, J. H.
    [J]. CARDIOLOGY, 2015, 131 : 285 - 285
  • [38] Expression of protease-activated receptor-1 (PAR-1): A differential marker for metastasis of squamous cell carcinoma of the head and neck (SCCHN)
    Zhang, X
    Hunt, JL
    Landsittel, DP
    Shin, DM
    Chen, ZG
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1309S - 1309S
  • [39] The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease
    Nilsen, Dennis W. T.
    Roysland, Michelle
    Ueland, Thor
    Aukrust, Pal
    Michelsen, Annika E.
    Staines, Harry
    Barvik, Stale
    Kontny, Frederic
    Nordrehaug, Jan Erik
    Bonarjee, Vernon V. S.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 510 - 521
  • [40] Activation of protease-activated receptor-1 (PAR-1) causes cyclooxygenase (COX) and MAP kinase mediated chloride secretion in an epithelial cell line.
    Buresi, MC
    Buret, A
    Hollenberg, MD
    MacNaughton, WK
    [J]. FASEB JOURNAL, 2001, 15 (04): : A501 - A501
12345